GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Square Pharmaceuticals PLC (DHA:SQURPHARMA) » Definitions » Other Long Term Assets

Square Pharmaceuticals (DHA:SQURPHARMA) Other Long Term Assets : BDT31,999 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Square Pharmaceuticals Other Long Term Assets?

Square Pharmaceuticals's other long-term assets for the quarter that ended in Dec. 2023 was BDT31,999 Mil.

Square Pharmaceuticals's quarterly other long-term assets increased from Jun. 2023 (BDT25,270 Mil) to Sep. 2023 (BDT27,495 Mil) and increased from Sep. 2023 (BDT27,495 Mil) to Dec. 2023 (BDT31,999 Mil).

Square Pharmaceuticals's annual other long-term assets increased from Jun. 2021 (BDT19,261 Mil) to Jun. 2022 (BDT22,227 Mil) and increased from Jun. 2022 (BDT22,227 Mil) to Jun. 2023 (BDT25,270 Mil).


Square Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Square Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Square Pharmaceuticals Other Long Term Assets Chart

Square Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,880.46 13,562.14 19,260.92 22,227.47 25,270.37

Square Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22,732.58 22,418.58 25,270.37 27,494.72 31,999.44

Square Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Square Pharmaceuticals (DHA:SQURPHARMA) Business Description

Traded in Other Exchanges
N/A
Address
Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. The company operates in Bangladesh and sells its products locally and internationally. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs.

Square Pharmaceuticals (DHA:SQURPHARMA) Headlines

No Headlines